This company listing is no longer active
APOL Stock Overview
Operates as a medical cannabis pharmaceutical company. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Apollon Formularies PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.000075 |
| 52 Week High | UK£0 |
| 52 Week Low | UK£0 |
| Beta | 0 |
| 1 Month Change | -78.57% |
| 3 Month Change | -93.18% |
| 1 Year Change | -95.31% |
| 3 Year Change | -99.79% |
| 5 Year Change | n/a |
| Change since IPO | -99.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| APOL | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -70.0% | -3.8% | -0.3% |
| 1Y | -95.3% | -14.6% | -0.7% |
Return vs Industry: APOL underperformed the UK Pharmaceuticals industry which returned 7.4% over the past year.
Return vs Market: APOL underperformed the UK Market which returned 6.3% over the past year.
Price Volatility
| APOL volatility | |
|---|---|
| APOL Average Weekly Movement | 25.1% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in GB Market | 11.0% |
| 10% least volatile stocks in GB Market | 3.2% |
Stable Share Price: APOL's share price has been volatile over the past 3 months.
Volatility Over Time: APOL's weekly volatility has increased from 16% to 25% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Stephen Barnhill | www.apollon.org.uk |
Apollon Formularies PLC operates as a medical cannabis pharmaceutical company. It offers hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products, such as cannabis oil vape, oral tincture, and perscribed capsules under the Apollon NAUSEA, Apollon PAIN, Apollon SLEEP, Apollon ANTI-INFLAMMATORY, Apollon SEIZURES, Apollon APPETITE, and Apollon CANCER names. Apollon Formularies PLC was founded in 2014 and is based in Douglas, the United Kingdom.
Apollon Formularies PLC Fundamentals Summary
| APOL fundamental statistics | |
|---|---|
| Market cap | UK£57.84k |
| Earnings (TTM) | -UK£1.05m |
| Revenue (TTM) | UK£362.72k |
0.0x
P/S Ratio0.0x
P/E RatioIs APOL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| APOL income statement (TTM) | |
|---|---|
| Revenue | UK£362.72k |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£362.72k |
| Other Expenses | UK£1.41m |
| Earnings | -UK£1.05m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did APOL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/06/04 15:50 |
| End of Day Share Price | 2024/06/04 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Apollon Formularies PLC is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.